The University of Southampton
University of Southampton Institutional Repository

Metabolic disturbances in non-alcoholic fatty liver disease

Metabolic disturbances in non-alcoholic fatty liver disease
Metabolic disturbances in non-alcoholic fatty liver disease
NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the ‘gold standard’ for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition
diabetes, inflammation, mitochondrion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), obesity
0143-5221
539-564
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Olufadi, Rasaq
b649c540-4a6b-482e-8abc-04c5be0e8b8d
Bruce, Kimberley D.
2065fe20-0e9e-4f1a-8463-71b832776fa1
Cagampang, Felino R.
7cf57d52-4a65-4554-8306-ed65226bc50e
Ahmed, Mohamed H.
ed037a05-9770-4c1f-80a8-bd79fc83ee35
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Olufadi, Rasaq
b649c540-4a6b-482e-8abc-04c5be0e8b8d
Bruce, Kimberley D.
2065fe20-0e9e-4f1a-8463-71b832776fa1
Cagampang, Felino R.
7cf57d52-4a65-4554-8306-ed65226bc50e
Ahmed, Mohamed H.
ed037a05-9770-4c1f-80a8-bd79fc83ee35

Byrne, Christopher D., Olufadi, Rasaq, Bruce, Kimberley D., Cagampang, Felino R. and Ahmed, Mohamed H. (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science, 116 (7), 539-564. (doi:10.1042/CS20080253).

Record type: Article

Abstract

NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the ‘gold standard’ for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition

Text
clinscinafld_2009.pdf - Version of Record
Restricted to Repository staff only
Request a copy

More information

Published date: April 2009
Keywords: diabetes, inflammation, mitochondrion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), obesity
Organisations: Dev Origins of Health & Disease

Identifiers

Local EPrints ID: 72615
URI: http://eprints.soton.ac.uk/id/eprint/72615
ISSN: 0143-5221
PURE UUID: 350a363e-b714-45d0-baf7-2f1063030fe2
ORCID for Christopher D. Byrne: ORCID iD orcid.org/0000-0001-6322-7753
ORCID for Felino R. Cagampang: ORCID iD orcid.org/0000-0003-4404-9853

Catalogue record

Date deposited: 18 Feb 2010
Last modified: 14 Mar 2024 02:47

Export record

Altmetrics

Contributors

Author: Rasaq Olufadi
Author: Kimberley D. Bruce
Author: Mohamed H. Ahmed

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×